Home > Journals > La Rivista Italiana della Medicina di Laboratorio > Past Issues > La Rivista Italiana della Medicina di Laboratorio 2020 Marzo;16(1) > La Rivista Italiana della Medicina di Laboratorio 2020 Marzo;16(1):4-6

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

L’OSSERVATORIO   

La Rivista Italiana della Medicina di Laboratorio 2020 Marzo;16(1):4-6

DOI: 10.23736/S1825-859X.19.00023-9

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: Italian

ISO 17822, quality for examinations with nucleic acid amplification

Marco PRADELLA

SIPMeL, Castelfranco Veneto, Treviso, Italia



ISO, the International Organization for Standardization, is preparing document ISO/TS 17822-2 on the quality control of nucleic acid amplification techniques (NAAT). ISO 17822-2 takes into consideration many aspects that affect quality. ISO 17822 prescribes the use of control materials and describes different types of them. ISO 17822-2 states that the laboratory shall decide the appropriate type and frequency of use of internal and external controls, but says however that the results must remain within the pre-established limits, without saying how the limits should be fixed. Worldwide quality control in medical laboratories is often not performed correctly. Quality costs represent 22% of the laboratory’s direct costs. The SIPMeL Quality and Accreditation Commission has therefore produced its recommendations on quality control, with the transposition of ISO 15198: 2004, reconfirmed also in 2018. Diagnostic system manufacturers have a primary role in this activity. The guidelines for quality control are in the document Clinical Laboratory Standards Institute (CLSI) C24.


KEY WORDS: Quality control; Accreditation; Nucleic acid amplification techniques; Microbiology

top of page